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Abstract
The serum protein a1-acid glycoprotein (AGP), also known as orosomucoid, is generally described as an archetypical positive
acute phase protein. Here, porcine AGP was identified, purified and characterized from pooled pig serum. It was found to
circulate as a single chain glycoprotein having an apparent molecular weight of 43 kDa by SDS-PAGE under reducing
conditions, of which approximately 17 kDa were accounted for by N-bound oligosaccharides. Those data correspond well
with the properties of the protein predicted from the single porcine AGP gene (ORM1, Q29014 (UniProt)), containing 5
putative glycosylation sites. A monoclonal antibody (MAb) was produced and shown to quantitatively and specifically react
with all microheterogenous forms of pig AGP as analyzed by 2-D electrophoresis. This MAb was used to develop an
immunoassay (ELISA) for quantification of AGP in pig serum samples. The adult serum concentrations of pig AGP were in
the range of 1–3 mg/ml in a number of conventional pig breeds while it was lower in Go¨ttingen and Ossabaw minipigs (in
the 0.3 to 0.6 mg/ml range) and higher in young (2–5 days old) conventional pigs (mean: 6.6 mg/ml). Surprisingly, pig AGP
was found to behave as a negative acute phase protein during a range of experimental infections and aseptic inflammation
with significant decreases in serum concentration and in hepatic ORM1 expression during the acute phase response. To our
knowledge this is the first description in any species of AGP being a negative acute phase protein.
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Introduction
Alpha-1-acid glycoprotein (AGP), also known as orosomucoid,
is a remarkable serum protein, among the most glycosylated
proteins in serum with 40–50% of its mass constituted by
carbohydrate and having a very low isoelectric point due to its
high content of sialic acid [1]. It has a number of microheter-
ogenous isoforms related to variations in its carbohydrate structure
and sialic acid content which are both altered in various disease
states (reviewed by [2]). It also may contain a number of amino
acid substitutions and in some species it is encoded by two genes
(ORM1 and ORM2) both with a number of alleles and variants, as
described in humans [3] and mouse [4]. In the pig one gene only
has been found ([5], ORM1 (Q29014, UniProt)) having some
degree of polymorphism [6]. There is extensive homology between
the pig gene and the human genes, including the same numbers of
putative glycosylation sites (5) and putative disulfide bonds (2). The
cDNA based pig AGP sequence fragment reported by [5] is
missing the two N-terminal amino acids and is 183 amino acids
long; adding the missing two amino acids (Q and I, by homology
to human gene) the theoretical pI and molecular weight of the pig
AGP polypeptide chain is 5.83 and 21140 Da, respectively. The
identification of pig AGP in classical 2-D electrophoresis, using
cross-reactive anti human AGP antibodies was published recently
[7]. Stone and Maurer (5) furthermore found that expression of pig
AGP is developmentally regulated with high liver expression in the
late stage foetus, decreasing 3–4 times in newborns and further
dropping to approximately 100 times less than foetal abundance in
the adult liver. This confirms other reports describing the protein
as constituting up to 50% of total serum protein in newborn pigs,
decreasing approximately 30 times in the adult circulation [8], [9].
This situation is the exact opposite to the one seen in humans
(reviewed by [10]). Apart from the early work by Charlwood et al.
[11] and the work of Lampreave and Pineiro [9] the molecular
features of pig AGP have been scarcely investigated. In addition to
the identification of pig AGP in 2-D electrophoresis as a
microheterogeneous acidic protein [7], a ConA-binding form of
pig AGP in bronchoalveolar lavage fluid (BALF) being micro-
heterogeneous with molecular weights in the range of 40–55 kDa
and a range of isoelectric points around 3–4 has been described by
[12].
Although widely studied and characterized, no definitive
function has been ascribed to AGP. It belongs to the lipocalin
family and has the ability to bind small lipophilic/cationic
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molecules [13], [14]. It has immunosuppressive properties,
including dampening neutrophil activation [15] and lymphocyte
stimulation [16], possibly correlated to its glycosylation [17] and
has also been described as having angiogenic properties [18]. The
main cell type producing AGP is the hepatocyte [2], [19] but other
cellular sources have also been described, notably activated
neutrophils [20] and blood leukocytes [21]. It has invariably been
described as a positive acute phase protein in all species studied,
including human, cow, mouse, dog, cat, rabbit, rat, and chicken
[1], [10], [22]. In the pig several reports propose to use pig AGP to
monitor acute phase responses (e.g. [23], [24], [25], [26]).
However, Lampreave et al. [27] and Eckersall et al. [28] both
described pig AGP as not changing its serum concentration during
the acute phase protein response to inflammation, and this was
also found by Asai et al. [29] after experimental porcine
reproductive and respiratory syndrome virus infection. In addi-
tion, we recently published the surprising finding that hepatic
expression of pig ORM1 was significantly decreased at 24 hours
after experimental infection with the pig lung pathogen Actinoba-
cillus pleuropneumoniae serotype 5b [30]. Also recently a proteomics
study, looking specifically at concanavalin A-binding glycoproteins
in BALF reported a local (lung), ConA-binding form of pig AGP
which responded to respiratory infection with Actinobacillus
pleuropneumoniae with either a slight decrease, a slight increase or
no change in BALF concentration, depending on the pig breed
(Pie´train, German Landrace and Hampshire, respectively) [12].
Yang et al. [31] also using proteomics identified a basic isoform of
pig AGP to be down-regulated in serum during experimental
infection of piglets with porcine respiratory and reproductive
syndrome virus. However, down-regulation of AGP as such could
not be demonstrated by one-dimensional Western blotting.
The acute phase protein response is a systemic serum response
to infection, trauma, and inflammation, occurring 12–24 hours
after tissue injury and mainly caused by changes in hepatic
synthesis rates [32]. This response, although an evolutionarily old,
generalized, innate defense reaction found in all metazoan species
studied so-far, has some intriguing features, including the fact that
acute phase proteins are found in most classes of serum proteins
with the notable exception of immunoglobulin. Although the acute
phase protein response in itself is highly conserved, it is made up of
different serum proteins in different species [22]. Examples of this
include CRP (a major human acute phase protein but not an acute
phase protein in the mouse), SAA (major human acute phase
protein, not an acute phase protein in the rat), and transferrin, the
latter being a negative acute phase protein in man, but a positive
acute phase protein in mouse [33].
Here we report a thorough molecular characterization of pig
AGP purified from pooled pig serum and provide conclusive
evidence both at transcriptional and protein levels that pig AGP
behaves as a negative acute phase protein in the pig during specific
infections as well as during inflammation-induced acute phase
responses.
Materials and Methods
Animal Experiments and Samples
A pool of serum from Landrace pigs from conventional herds
was used as the starting material for purifying pig AGP. Serum
samples for quantification of pig AGP during experimentally
induced acute phase responses originated from animal experi-
ments described in [34](Actinobacillus pleuropneumoniae serotype 5
experimental infection), [35](aseptic inflammation), [36](Actinoba-
cillus pleuropneumoniae serotype 2 and serotype 6 experimental
infections), [37] (Streptococcus suis experimental infection) and [38]
(Staphylococcus aureus experimental infection). Aseptic inflammation
animals were Large White/Landrace/Pie´train cross-breds, pigs in
the other groups were either Landrace/Yorkshire or Landrace/
Yorkshire/Duroc crosses.
Furthermore, serum samples were obtained from breeding
herds of Landrace, Yorkshire and Duroc breeds around 2 months
of age (as described in [39]) and from SPF as well as non-SPF
production herds around 20 weeks of age (described in [40]). In
addition, serum samples were obtained from following types of
pigs housed under standard conditions in experimental stables:
Ossabaw minipigs (courtesy of Prof. Mike Sturek, Indiana
University Medical School, IN, US), Go¨ttingen minipigs (courtesy
of Dr. Berit Christoffersen, Novo Nordisk A/S, Denmark), and
Yorkshire/Landrace crossbreds (courtesy Dr. Jan Stagsted, Aarhus
University, Denmark). Finally, serum samples were obtained from
cross-breds (offspring from Danish Landrace/Yorkshire sows and
Duroc or Hampshire boars) a few days after birth and from the
same animals at one month of age. These pigs were either from a
conventional herd or kept at the experimental stables at the
National Veterinary Institute (courtesy Dr. Klara T. Lauritsen,
National Veterinary Institute, Technical University of Denmark).
All animal experiments were conducted in accordance with
local legislation (Animal Experimentation Act of Denmark and
Ethical Committee for Animal Research at the University of
Zaragoza, both in accordance with the Council of Europe
Convention ETS 123). All experimental procedures involving
Ossabaw minipigs were approved by the Indiana University
Animal Care and Use Committee and complied fully with the
Guide for the Care and Use of Laboratory Animals and the
American Veterinary Medical Association Panel on Euthanasia.
Purification of Pig AGP
Pig AGP was purified from pooled pig serum by salting out with
350 mg ammonium sulfate added per ml of serum adjusted to
pH 5.5 with 1 volume of 0.2 M sodium acetate. The supernatant
was collected by centrifugation, dialyzed and subjected to cation
exchange chromatography (CM-Sepharose) at pH 3 at low ionic
strength (0.1 M sodium acetate), yielding highly enriched pig AGP
in the run-through. The more basic isoforms of pig AGP could be
eluted at higher pH and higher ionic strength from the same ion
exchange column. The run-through fraction was further purified
by anion exchange chromatography on Q Sepharose at pH 5.5 at
low ionic strength, followed by a polishing step on an S100 gel
filtration column. All operations were performed with E280
monitoring and analyzing fractions by SDS-PAGE and/or
Western blotting using a commercially available rabbit anti-
human AGP antibody (see below).
Preparation of Monoclonal Antibody and Development
of ELISA
Purified pig AGP at approximately 1 mg/ml in PBS was used
for immunizing a group of 5 mice. Briefly, the purified antigen
was mixed by extensive agitation with one volume of Freund’s
Incomplete Adjuvant (Difco, Detroit, MI, USA), tested for
emulsion stability by floating a droplet on a water surface, and
injected subcutaneously into the back of the neck of the mouse,
using 100 ml (50 mg) for each injection. Three immunizations
were performed with 14 day intervals. Fourteen days after the
third immunization a serum sample was obtained from each
mouse by tail-bleeding. The mouse sera were tested for
reactivity with pig AGP in porcine serum by immunoblotting
and the mouse with the best reactivity was chosen for
intraperitoneal boosting with the purified antigen with no
adjuvant. The mouse was killed by cervical dislocation 4 days
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later and the spleen immediately used for preparation of
splenocytes which were then fused to myeloma cells (P3663
Ag.8653 murine myleoma cells; ATCC,Rockville, MD, USA).
Fusion and screenings were carried out essentially as described
by [41] using cloning by limiting dilution in ELISA, with
purified pig AGP as the positive screening antigen and serum
from a boosted, immunized mouse as a positive control. The
two best performing clones were selected for further cell culture,
purification of monoclonal antibodies (MAbs) from the cell
culture medium and tested for performance in ELISA for
quantification of pig AGP. Purification of MAbs from superna-
tants of cell cultures grown in flasks was done by affinity
chromatography on protein A-agarose (Kem-En-Tec, Glostrup,
Denmark) as described previously [42]. Monoclonal antibodies
were isotyped using an anti-mouse Ig subclass-specific kit
(Mouse MonoAb-ID Kit (HRP), Zymed Laboratories Inc.,
Invitrogen). Specificity of MAbs was tested by Western blotting
(see below) using unfractionated pig serum. The ELISA was
optimized with respect to intra- and interassay variation and
linearity under dilution, this latter point being addressed
specifically as it was known that pig AGP is microheterogeneous
and therefore populations having different molecular composi-
tion might react differently with the MAb. This was analyzed
by two-dimensional (2-D) electrophoresis followed by blotting
(see below) of pig sera with widely differing concentrations of
pig AGP and by looking at parallelism of dilution curves for
different pig AGP samples in the ELISA.
The final quantitative immunoassay for pig AGP was in the
format of a competitive ELISA using the MAb 1.62. MAb 1.62
was coated at 1 mg/ml in 0.1 M carbonate pH 9.6 in Maxisorp
microtiter plates (Nunc, Roskilde, Denmark) using 100 ml/well
overnight at 4uC. Blocking buffer (1% bovine serum albumin
(Sigma-Aldrich, Hvidovre Denmark) in washing buffer (0.05%
Tween 20 in PBS)) was added at 200 ml/well and incubated for 30
minutes at standard conditions (21uC, on a shaking table). Then
plates were washed in washing buffer (4 times) and incubated with
a mix of sample at an appropriate dilution (50 ml) and biotinylated,
purified pig AGP at an appropriate concentration (50 ml) i.e.
100 ml in each well. The blocking buffer was used as dilution
buffer. This was incubated for 1 hour at standard conditions
followed by washing as before and then horse radish peroxidase
conjugated streptavidin (P397, DAKO, Glostrup, Denmark) was
added at 1/2000 for 1 hour at standard conditions. After a final
wash as before plates were developed with one-component
peroxidase substrate solution (TMB-plus, Kem-En-Tec, Glostrup,
Denmark) 100 ml/well. Color development was then stopped by
adding 100 ml 0.5 M sulfuric acid to each well. For calibration,
each plate contained a dilution series of a standard pig serum pool,
itself calibrated against a commercially available pig AGP
standard (Saikin Kagaku Institute Ltd, Sendai, Japan). All samples,
including the standard were applied in duplicates. The non-
optimized lower limit of quantification was 10 mg/ml. Optical
densities of wells were read at 450 nm subtracting unspecific
coloration at 650 nm using an automatic plate reader (Thermo
Multiskan Ex spectrophotometer, Thermo Scientific, Waltham,
MA, USA). Sample values were calculated from the curve fitted to
the readings of the standard (using Ascent software v. 2.6, Thermo
Scientific).
Pig haptoglobin was analyzed in a sandwich ELISA as described
in Sorensen et al. (2006) [37]. The lower limit of quantification
was 50 mg/ml as defined by the lowest concentration of the
standard.
For use in the competitive immunoassay, purified pig AGP was
biotinylated using biotin-N-hydroxysuccinimide (BNHS, Sigma-
Aldrich Denmark, Brøndby, Denmark). Pig AGP at .2 mg/ml in
0.1 M carbonate pH 8.2 was mixed with 0.2 volumes of BNHS in
N-methylpyrrolidone (2 mg/ml, fresh solution), incubated for 2
hours and dialysed against PBS overnight at 4uC. The working
concentration of biotinylated pig AGP was determined by
titrations in ELISA without competing antigen.
Analysis of Pig AGP and Deglycosylated Pig AGP
For deglycosylation, PNGase F from QAbio (Himmelried,
Switzerland) was used, following the recommendations of the
manufacturer and using desialylated pig AGP as the substrate.
Removal of sialic acid (N-acetylneuraminic acid) was accom-
plished using Clostridium perfringens neuraminidase (Sigma-Aldrich,
N-2876) at 0.1 mg enzyme per mg of pig AGP in 0.05 M sodium
acetate pH 5.2 and incubation overnight at 37uC.
For one-dimensional SDS-PAGE, Novex bis-tris 12%, 1 mm
polyacrylamide gels were used in a Novex apparatus (Kem-En-
Tec, Glostrup, Denmark) in the NuPAGE buffer system according
to the manufacturer’s instructions, loading 20 ml sample in
NuPAGE LDS sample buffer with reducing agent, adjusting the
sample to OD (280 nm) = 0.1 (PBS) before mixing with sample
buffer. Pre-electrophoresis was at 50 V, 20 minutes, followed by
electrophoresis at 200 V for approx. 120 minutes. Silver-staining
was performed according to the protocol of [43]. Rabbit anti-
human AGP (A011), 1/500, alkaline phosphatase conjugated
swine anti-rabbit IgG (D306), 1/2000, and alkaline phosphatase
conjugated goat anti-mouse IgG (D486), used 1/2000, all from
DAKO (Glostrup, Denmark) were employed for Western blotting
performed as described previously [34]. The monoclonal antibody
(MAb 1.62) was used at a concentration of 1.5 mg/ml. Blots were
developed with 4-Nitro-blue-tetrazolium/5-bromo-4-chloro-3-in-
dolyl-phosphate (NBT/BCIP) tablets (cat. no. 11 697 471 001,
Roche, Hvidovre, Denmark) after the manufacturer’s instructions,
terminating color development by washing the blot with several
changes of MilliQ water.
Two-dimensional electrophoresis (2-D electrophoresis) was
performed as a combination of isoelectric focusing in immobilized
pH-gradients (IPG) in the first, and SDS-PAGE in the second
dimension. For both dimensions, medium-size
(140 mm6140 mm61.5 mm) home-made gels were used, as
described in [44], but in the pH range 2.5–5 for IPGs [7]. Three
different conditions were applied for the IPG step: a) classical
reducing-denaturing (including urea, CHAPS and DTT), b) non-
reducing (classical protocol, but omitting DTT and iodoaceta-
mide; [45]), and c) non-denaturing/non-reducing (native IPG
followed by non-reducing SDS-PAGE). For simplicity, analysis
conditions will further in the text be called "reduced" (a), "non-
reduced" (b), and "non-denatured" (c) sample. If comparison of
two serum specimens was needed on one gel, two first-dimensional
IPG strips were cut to appropriate size and assembled tail to head
on the same SDS-PAGE gel. 2-D study under different conditions
allowed studying the protein in a completely unfolded condition
(a), without intracellular disulfide bonds (b) and in a more or less
native form (c), at least regarding the first dimensional step.
Detection was done by silver-staining (44) or immunoblotting [46].
For the latter, following 2-D electrophoresis proteins were
transferred onto nitrocellulose by semi-dry blotting. Overall
protein pattern was visualized with the fluorescent protein stain
ruthenium(II) tris(bathophenanthroline disulfonate)(RuBPS). After
probing with specific antibody and horse radish peroxidase-
conjugate, immunoreactive spots were detected on x-ray film by
enhanced chemoluminescence (ECL, GE Healthcare Life Scienc-
es, Munich, Germany).
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Gene Expression Analysis
For gene expression analyses (Actinobacillus pleuropneumoniae
serotype 2 and 6, and the Staphylococcus aureus experiments), RNA
extraction, primer design, cDNA synthesis, preamplification, and
qPCR conditions have been described previously in (30, 38).
Briefly, RNAlater (Qiagen) stabilized liver tissue was homogenized
and total RNA was extracted using RNeasy (Qiagen, Denmark) or
Trizol (Invitrogen, Denmark). Purity and quantity of extracted
total RNA was assessed by UV absorption on a Nanodrop ND-
1000 spectrophotometer (Saveen and Werner AB, Limhamn,
Sweden). RNA integrity number was measured on an Agilent
2100 Bioanalyzer (Agilent Technologies, Nærum, Denmark) using
the RNA 6000 Nano Kit. Extracted RNA was converted into
cDNA by reverse transcription of 500 ng total RNA using the
QuantiTECT Reverse Transcription kit (Qiagen). Pre amplifica-
tion was done using TaqMan PreAmp Master Mix (Applied
Biosystems, Foster City, CA). Pre amplified cDNA was diluted at
least 1:4 in low EDTA TE-buffer (VWR – Bie & Berntsen) before
qPCR. QPCR was performed in 48.48 Dynamic Array Integrated
Fluidic Circuits (Fluidigm Corporation, CA, USA) combining 48
preamplified samples with 48 primer sets for 2304 individual and
simultaneous qPCR reactions. The following cycle conditions were
used: 2 min at 50uC, 10 min at 95uC, followed by 35 cycles with
denaturation for 15 s at 95uC and annealing/elongation for 1 min
at 60uC. Melting curves were generated after each run to confirm
a single PCR product (from 60uC to 95uC, increasing 1uC/3 s.).
Data were acquired using the Fluidigm Real-Time PCR Analysis
software 3.0.2 (Fluidigm Corporation). Pre-processing and relative
quantification of expression data were done as previously
described [47]. Briefly, several stably expressed reference genes
were used for normalization. These genes were validated using
both GeNorm [48] and NormFinder [49] and included hypoxan-
thine phosphoribosyl-transferase 1 (HPRT1), TATA box binding
protein (TBP), tryptophane 5-monooxygenase activation protein,
zeta polypeptide (YWHAE), and peptidylprolyl isomerase A
(PPIA) (for the Staphylococcus aureus experiment) and HPRT1 and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for the
Actinobacillus pleuropneumoniae experiment.
Results of relative expression levels were compared and tested
for statistical significance using Mann Whitney’s non-parametric
two tailed test for the Actinobacillus pleuropenumoniae experiment. For
the Staphylococcus aureus experiment the control group was too small
(n = 2) to allow statistically based comparisons to be made.
Results
Identification, Purification and Characterization of Pig
AGP
In silver-stained SDS-PAGE and Western blotting purified pig
AGP appeared under reducing conditions as a single broad band
with a mean apparent molecular weight around 43 kDa, as
indicated by its reactivity with rabbit anti-human AGP (Fig. 1A,
left panel). With this antibody, unspecific reactions with a number
of unrelated serum proteins were seen in salted-out serum,
however the identity of this band was confirmed by the identical
position and appearance of purified pig AGP in reducing SDS-
PAGE and in Western blotting (Fig. 1A, lane 2, both panels).
Sialidase treatment of purified pig AGP shifted its apparent
molecular weight to 36 kDa, appearing as a single broad band that
was still fully reactive with the rabbit anti-human AGP antibody in
Western blotting (Fig. 1A, lane 3, both panels). Subsequent
PNGase treatment left an immunoreactive narrow band at an
apparent molecular weight of 26 kDa (Fig. 1B, lane 3). Finally, a
high-titered, highly specific mouse antiserum was obtained after
immunization with purified pig AGP (Fig. 1C), and the
monoclonal mouse anti-pig AGP antibody subsequently developed
from this mouse was shown to react with unpurified, purified as
well as sialidase treated purified pigAGP in Western blotting
(Fig. 1D). In both Western blots with serum (Fig. 1A and Fig. 1D)
staining of higher molecular weight bands is seen, probably
representing unspecific staining by the secondary antibody.
By 2-D electrophoresis under reducing conditions pig AGP was
identified as one of the most acidic pig serum proteins having
several isoforms spanning the molecular weight range 44–55 kDa
and the pI range 3.6 to 4.3. The high molecular weight isoforms
had the low pI and low molecular weight isoforms had higher pIs,
giving the pig AGP isoform population a characteristic downwards
‘‘slope’’ going from low pI to high pI (Fig. 2A, arrow). When run
under non-reducing conditions the pig AGP population showed
two molecular weight subpopulations, one slightly little less
abundant population with a molecular weight 2–4 kDa higher
than the other and lacking the most basic pI forms (Fig. 2A, middle
panel). The pI differences between the different isoforms were
similar for both populations. The MAb 1.62 reacted specifically
and indiscriminately with all pig AGP isoforms (Fig. 2B and 2C)
and reliably reproduced the pattern and intensity of spots in two
serum samples having a two-fold difference in pig AGP
concentration as seen with general silver-staining of the gel or
RuBPS staining after blotting (Fig. 2C). Reduced porcine AGP
had a higher apparent molecular weight than non-reduced by 2-D
electrophoresis (Fig. 2A, left and middle panel, respectively)
suggesting the presence of one or more intra-molecular disulfide
bonds in the molecule. Omission of denaturing compounds in IPG
prior to non-reducing SDS-PAGE changed the AGP pattern to
less distinctly separated isoforms, a lower molecular weight slope,
and markedly lower pI (Fig. 2A, right panel).
Purified pig AGP comprised the full population of isoforms;
upon desialylation the slope was completely lost, and the whole
population moved to a lower molecular weight (around 40 kDa)
and a slightly higher pI (in the 4.3–4.5 range)(not shown), however
a division into two populations was still apparent. This pattern was
retained after PNGase treatment, however at a molecular weight
from 26–28 kDa (not shown).
Antibody Reactivity
After immunization with unmodified, purified pig AGP, four
out of five mice yielded high titers of pig AGP specific antibodies
(an example of mouse antiserum reactivity is shown in Fig. 1C). A
desialylated version of the same pig AGP preparation was also
used for immunization in five additional mice, however yielded
antisera of lower titer towards intact porcine AGP and no cloning
was attempted from these mice. Subsequent establishment of
hybridoma cell lines using spleen cells from the most highly
reacting mouse yielded several hybridoma clones producing
monoclonal antibodies (MAbs) reacting specifically with pig
AGP. One clone (MAb 1.62) of the IgG1 subtype with type k
light chains was used to probe Western blots and showed similar
reactivity with pig AGP in unfractionated pig serum, purified pig
AGP and desialylated purified AGP (Fig. 1D), closely resembling
the reactivity of the polyclonal rabbit anti human AGP antibody
(Fig. 1A and B) although with higher specificity. Non-reduced
samples were detected with higher sensitivity than reduced
samples (not shown), which was a clear advantage for the planned
application of the antibody in ELISA. Therefore, also 2-D
electrophoresis for Western blot testing of this antibody was
performed under these conditions. Thus separated pig serum
demonstrated the specificity (Fig. 2B) and the reactivity of MAb
1.62 with all pig AGP isoforms visible by silver-staining, reliably
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reflecting the concentration of pig AGP in two different pig sera
(Fig. 2C).
ELISA
It was first attempted to develop a classical sandwich ELISA for
quantification of pig AGP, however we did not succeed in
identifying mutually non-excluding MAb pairs. Instead, a com-
petitive format was validated, in which biotinylated, purified pig
AGP was co-incubated with sample, being blocked in its binding to
the catching antibody by any pig AGP present in the sample. MAb
1.62 was used as the catching antibody, as described in detail
above (Materials and Methods). The assay proved robust and
precise and showed parallel titration curves with all samples tested,
including the standard (Saikin Kagaku Institute Ltd.), allowing for
accurate quantification over a large dilution range (Fig. 3A). As
described above, to test whether there was any bias in the reaction
of MAb 1.62 with the isoforms of pig AGP, a 2-D electrophoretic
analysis was run with two individual pig sera side by side, one
having a high (1692 mg/ml) and another one a lower concentra-
tion of AGP (827 mg/ml) as measured by the ELISA. As can be
seen in Fig. 2C, there was a good agreement between the relative
silver staining intensities of pig AGP in the two samples on one
hand and the relative staining intensities seen after blotting with
general protein staining (RuBPS) as well as with MAb 1.62
Figure 1. Characterization of pig AGP by SDS PAGE and Western blotting. A: Left panel: Silver-stained SDS PAGE, from the left: Salted-out
pooled pig serum supernatant; purified pig AGP; purified pig AGP after sialidase treatment. Right panel: Western blot with the same samples probed
with rabbit anti human AGP (DAKO). Arrow: Position of pig AGP in salted-out serum supernatant. B: Western blot probed with anti human AGP, from
the left: Purified pig AGP; purified AGP after sialidase treatment; purified AGP after sialidase and PNGase F treatment; buffer control for PNGase F
treatment. C: Western blot of pooled pig serum probed with antiserum (1/500) from mouse immunized with purified pig AGP (see
text)(representative example). D: Western blot probed with MAb 1.62, from the left: Pooled pig serum; purified pig AGP; purified pig AGP after
sialidase treatment.
doi:10.1371/journal.pone.0068110.g001
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Figure 2. Characterization of pig AGP by 2D electrophoresis and 2D blotting. A: Pig AGP 2-D electrophoresis, influence of sample
preparation conditions, from left to right: reduced sample, non-reduced sample, non-denatured sample. Close-up from gels with pH gradient 2.5–5,
individual pig serum sample (B16/221). Mw markers: 30,43,67,94 kDa (from bottom). Arrow: Pig AGP isoforms. B: The reaction of MAb 1.62 with non-
purified pig PAGP isoforms by 2-D electrophoresis. Individual pig serum sample (Aus), non-reducing, complete gel/blot with IPG pH 2.5–5 in the first
dimension, left: silver-stained, right: blot probed with MAb 1.62. Mw markers: 14, 20, 30, 43, 67, 94 kDa (from bottom). Arrow: Pig AGP isoforms C:
Close-up of 2-D electrophoresis of two individual pig sera (827 mg/ml (left), 1692 mg/ml (right)), silver-stained (top), blotted and stained by RuBPS
(general protein stain)(middle), and the same blot subsequently probed with MAb 1.62 (bottom). Non-reducing, pH gradient 2.5–5. Arrow: Pig AGP
isoforms.
doi:10.1371/journal.pone.0068110.g002
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immunostaining on the other hand, all of these reflecting the
concentration differences as determined by the ELISA. In the blot
it was also evident that MAb 1.62 reacted similarly with all visible
molecular species of pig AGP, reproducing to large extent the
relative intensities seen by silver-staining (Fig. 2C). This was also
the case when – instead of non-reducing conditions – non-
reducing/non-denaturing conditions were applied in 2-D electro-
phoresis (not shown).
Serum Concentrations of Pig AGP
The non-biased reaction of MAb 1.62 with all pig AGP
molecular species at different concentrations was reflected in the
parallelism of dilution curves seen with two individual pig sera, a
commercial standard preparation (Saikin Kagaku Institute Ltd.)
and pig AGP purified in our laboratory (Fig. 3A).
Serum concentrations in young (2–5 days old) cross-bred piglets
from a conventional herd and from experimental stables were all
decreased by a factor of around 6 at day 26–31, with the mean
concentration in young animals (N = 31) being 6.6 mg/ml and in
the same 1 month old animals being 1.1 mg/ml (Fig. 3B).
In production pigs (Duroc (DD), Landrace (LL) and Yorkshire
(YY) purebreds) from conventional breeding herds, pig AGP
serum concentrations showed quite a large variation with means of
1.8, 1.3 and 1.5 mg/ml, respectively, in 2 months old LL, DD and
YY pigs (Fig. 3C). Similarly, in conventional production herds and
specific pathogen free (SPF) herds a rather large variation was seen
and the means were 2.2 (non-SPF) and 2.5 mg/ml (SPF), i.e. a
little lower, although not significant, in conventional herds
compared to SPF herds. In two minipig breeds (Ossabaw and
Go¨ttingen, respectively) both mean and variance were much lower
(Ossabaw: 0.3 mg/ml, Go¨ttingen: 0.5 mg/ml) and this was also
the case for Yorkshire/Landrace crossbreds kept under experi-
mental conditions (mean 0.6 mg/ml) (Fig. 3C).
Pig AGP Serum Concentrations During Infection and
Inflammation
In experimental Streptococcus suis (Gram positive bacterium)
infection as well as in experimental aseptic inflammation induced
by subcutaneous turpentine injection (Fig. 4A and 4B, respectively)
the haptoglobin acute phase response (approximately 20 fold
increase) was mirrored by a substantial decrease in pig AGP serum
concentrations, peaking at 5 days (S. suis) and 2 days (inflamma-
tion) after challenge. In the S. suis experiment pig AGP dropped
from a day 0 concentration of around 2.5 mg/ml to appr. 1.4 mg/
ml at day 5 and inflammation caused a drop from 1.5 mg/ml to
1.1 mg/ml at day 2 in these pigs (Fig. 4A and 4B). Experimental
infection with the respiratory Gram negative pathogen Actinoba-
cillus pleuropneumoniae also caused a decrease in pig AGP serum
concentrations, concomitantly with an increase in haptoglobin
(Fig. 4C and (33)), dropping from around 0.8 mg/ml to 0.6 mg/
ml at day 2 p.i. With the Gram positive pathogen Staphylococcus
aureus (Fig. 4D) a 3–5 fold increase in haptoglobin at 30–48 hours
after challenge was accompanied by a small decrease in pig AGP,
going from a mean in 5 animals around 1.1 mg/ml to 0.7 mg/ml,
however with a big animal to animal variation.
Pig mRNA AGP Expression in Liver
Concurrently with a 10–20 times increase in the relative
expression of the pigMAP gene (ITIH4) a down-regulation of the
pig AGP gene (ORM1) expression was seen in liver tissue 24 hours
after experimental infection with two different serotypes of
Actinobacillus pleuropneumoniae in separate experiments (serotype 2
and serotype 6), compared to a shared control group of six animals
(Fig. 5A). The down-regulation of the pig AGP gene amounted to
2–4 fold. Also looking at the liver response, experimental
Staphylococcus aureus infection resulted in an approximate 4 fold
reduction in ORM1 expression at 30–48 hours after challenge,
concomitantly with a pigMAP gene induction of around 20 fold
Figure 3. ELISA quantification of pigAGP. A: Titration of purified pig AGP, pig AGP standard (Saikin Kagaku Institute Ltd.), and two individual pig
sera in competitive MAb 1.62 based ELISA. B: Serum concentrations of pig AGP in newborn piglets and in 1-month old piglets (Landrace, Duroc,
Yorkshire crossbreds, N = 31). Bars indicate mean and SEM. C: Serum concentrations of pig AGP in different pig breeds and rearing conditions
(individual samples), mean and SEM shown. DD: Duroc (2 months, herd) LL: Landrace (2 months, herd) YY: Yorkshire (2 months, herd) Ossabaw
minipigs, Experimental stables (14–16 months of age) Go¨ttingen minipigs, Experimental stables (41–47 months of age) L/Y: Landrace/Yorkshire
crossbreds (experimental stables, 8–9 months of age) Conventional herd (5 months, D/L/Y cross bred production pigs) SPF herd (5 months, D/L/Y
cross bred production pigs).
doi:10.1371/journal.pone.0068110.g003
Pig a1-Acid Glycoprotein
PLOS ONE | www.plosone.org 7 July 2013 | Volume 8 | Issue 7 | e68110
Pig a1-Acid Glycoprotein
PLOS ONE | www.plosone.org 8 July 2013 | Volume 8 | Issue 7 | e68110
and a haptoglobin gene expression fold change around two
(Fig. 5B).
Discussion
Purification of pig AGP, as followed by its cross-reactivity with
polyclonal rabbit anti human AGP was relatively straightforward,
taking advantage of the high solubility and the acidic nature of the
protein, as compared to most other serum proteins. The purified
protein gave rise to a broad band in SDS-PAGE. Molecular
heterogeneity was also indicated in the first ion exchange
chromatography step (cation exchange, CM Sepharose), as pig
AGP was found both in the run-through from the CM Sepharose
column and in eluted fractions obtained by increasing the pH of
the buffer, corresponding to more acidic and less acidic isoforms,
Figure 4. Serum concentrations of pigAGP during the acute phase response. Serum concentration of pig AGP (left) and pig haptoglobin
(right) at different days post infection after experimental Streptococcus suis (A), Actinobacillus pleuropneumoniae (haptoglobin data not included) (B),
and Staphylococcus aureus (C) infection and after aseptic inflammation (D). Note: In the Staphylococcus aureus experiment, only two infected pigs
were sampled at 48 hours.
doi:10.1371/journal.pone.0068110.g004
Figure 5. Hepatic expression of pig AGP gene during acute infection. A: Relative expression levels of pig AGP (left) and pigMAP (right) (mean
of controls (CTRL, N= 6) set to 1) at 24 hours after experimental infection with Actinobacillus pleuropneumoniae serotype 6 (Ap6) and serotype 2 (Ap2),
respectively, as indicated. Values for all individual animals are shown. Error bars depict SEM. Analysis was done on liver tissue samples by qPCR (see
text). P,0.01: **, not significant: NS. B: Relative expression levels (mean of controls (CTRL, N = 2) set to 1) in Staphylococcus aureus liver samples 30
(N= 3), 36 (N= 2) and 48 (N= 2) hours after i.v. infection with the bacterium as determined by qPCR, pig AGP (left), pig MAP (middle) and haptoglobin
(right). Controls received sterile isotonic saline and were euthanized at 48 hours. Values for individual animals are shown. Error bars depict SEM.
doi:10.1371/journal.pone.0068110.g005
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respectively. The more acidic isoforms had a slightly higher
molecular weight than the less acidic isoforms (not shown). The
mean molecular weight of the whole population was around
43 kDa showing up as one broad band in SDS-PAGE and as two
parallel isoform series by 2-D electrophoresis (molecular weight:
44–55 kDa, see below). This suggests that part of the molecular
heterogeneity of pig AGP may be explained by differences in the
extent of sialic acid content, correlating increasing molecular
weight with lower pI. There were additional sources of heteroge-
neity, however, as sialidase mediated removal of sialic acid did not
noticeably sharpen the band in SDS PAGE. In contrast, complete
N-deglycosylation led to a narrow band with no apparent
molecular weight heterogeneity. Sialidase treatment resulted in
an approximately 7 kDa decrease in molecular weight corre-
sponding to around 22 sialic acid (N-acetyl neuraminic acid)
moieties, suggesting that all five potential N-glycosylation sites
were glycosylated with highly branched, complex-type N-glycans.
This was confirmed by PNGase F treatment, reducing the
molecular weight of pig AGP to 26 kDa, 17 kDa less than the
intact protein. Assuming a typical tetra-antennary N-glycan
molecular weight of 3606 Da, this corresponds to almost full
occupancy of all five potential N-glycosylation sites with tetra-
antennary glycans. The aglycan apparent molecular weight of pig
AGP of 26 kDa is higher than the theoretical molecular weight as
predicted from the sequence of the gene (21140 D) (Q29014,
UniProt). This could be due to the presence of other post-
translational modifications, including O-glycosylation or unusual
glycan structures, as described in bovine and caprine AGP [50]
possibly less amenable to hydrolysis by PNGase F. The isoelectric
point (3.6–4.3) is lower than that predicted from the polypeptide
alone (5.83), most likely due to the presence of sialic acid in the
intact protein. In addition, phosphate groups may add to the low
isoelectric point, as the polypeptide sequence contains several
potential phosphorylation sites and phosphorylation was demon-
strated for bovine AGP in a recent paper [51]. The presence of
approximately 40% carbohydrate, the high sialic acid content and
low pI are similar to AGPs of a range of other species [1], [2], [49],
[52], [53]. Two-dimensional electrophoresis revealed the presence
of distinct pI/molecular weight isoforms distributed on two
dominant molecular weight subpopulations (44–55 kDa) and 5–7
different pI forms (3.6–4.3). This agrees well with a molecular
model in which the molecular weight heterogeneity is accounted
for by the polypeptide, while most of the rest of the heterogeneity
stems from sialic acid (explaining the downward ‘‘slope’’ when
going from higher to lower molecular weight and lower to higher
pI) with some pI heterogeneity still residing in the polypeptide
chain (charged/non-charged amino acids with little molecular
weight difference) [54]. The same overall pI and molecular weight
range and pattern of heterogenity was found by [7] and by [12] for
Pie´train pig lectin (concanavalin A) binding AGP, identified by
mass spectrometry in BALF.
Although immunization with desialylated pig AGP yielded less
reactive antibodies (not shown) the monoclonal antibody produced
(MAb 1.62) did not show any difference in reactivity with asialo- or
deglycosylated pig AGP in Western blotting and reacted uniformly
with all pI and molecular weight isoforms in 2-D electrophoresis
blots. Thus, differences in concentrations were reflected reliably by
the reactivity with MAb 1.62 on the blot. This was seen with semi-
purified and purified forms as well as with a range of different sera.
Likewise, the competitive ELISA based on MAb 1.62 was
performing accurately with a range of sera as well as purified
forms of pig AGP, including a commercial pig AGP standard, as
seen by parallel titration curves (linearity under dilution). This is
not trivial, as the differently glycosylated isoforms of pig AGP and
thereby pig AGP populations of different compositions might
theoretically have different reactivity with a given monoclonal
antibody.
To our knowledge this is the first described monoclonal
antibody based quantitative immunoassay for pig AGP, supple-
menting a commercially available single radial immunodiffusion
assay based on polyclonal antibodies (Seikin Kagaku Institute Ltd.)
and more complicated and semi-quantitative methods as e.g.
densitometry of silver-stained 2-D gels [12].
Using this ELISA we show that perinatal AGP serum
concentrations were elevated compared to the concentration in
1 month old pigs (Landrace/Yorkshire/Duroc/Hampshire cross-
es), confirming earlier reports in which a protein, tentatively
identified as pig AGP and named fetospecific-like a-glycoprotein
was found to be the major serum protein, accounting for 50% of
the serum proteins at 12.7 mg/ml at birth and 0.24 mg/ml in
adult (6 months) sera [8]. In a follow-up to this work pig AGP was
identified and quantified by crossed immunoelectrophoresis using
a polyclonal polyspecific rabbit anti pig serum and by analysis of
amino acid and carbohydrate composition of the purified protein
[9], confirming the preliminary characterization of pig AGP by
[11]. Itoh et al. [23] determined pig AGP concentrations to be
around 14 mg/ml in 1 day old Landrace pigs, dropping to around
0.7 mg/ml at 4 weeks of age. Developmental regulation was also
demonstrated by [5] showing approximate 100 times decrease in
the pig AGP mRNA level of fetal liver as compared to adult pig
liver. We find 2–5 days old pigs to have a serum concentration of
6.6 mg/ml, possibly reflecting that a rapid decrease in pig AGP
serum concentration occurred in the first few days after birth, and
we determined the 1 month serum concentration to be 1.1 mg/ml.
This is a typical adult level of pig AGP as found in a number of
production breeds (Landrace, Duroc and Yorkshire) under
standard production herd conditions, where concentration means
range from 1.3 to 2.5 mg/ml. In contrast, concentrations in two
breeds of minipigs (Ossabaw and Go¨ttingen) were lower (0.3 mg/
ml and 0.5 mg/ml, respectively) and a low concentration (0.6 mg/
ml) was also found in a group of adult (9 months old) Yorkshire/
Landrace pigs. Itoh et al. [23] reported an upper normal limit of
0.5 mg/ml for adult pigs (Landrace), Asai et al. [29] described
concentrations to be in the range of 0.5–1 mg/ml in 4 weeks old
SPF pigs, and Eckersall et al. [28] stated 0.3 to 0.6 mg/ml as the
pig AGP concentration in 10 kg pigs. All of these studies used a
single radial immunodiffusion kit from Saikin Kagaku Ltd.
Lampreave and Pineiro [8] using the same method with an in-
house standard measured 0.24 mg/ml as the mean concentration
in normal pigs.
Pig AGP was found here to behave as a negative acute phase
protein reacting with a 30–50% decrease in serum concentration
during experimental Streptococcus suis, Actinobacillus pleuropneumoniae,
and Staphylococcus aureus infections and during experimental, aseptic
inflammation. At the same time the positive acute phase protein
haptoglobin, determined in parallel in the same samples reached
its peak concentration. This is noteworthy considering the diversity
of the experimental treatments: Streptococcus suis is a Gram positive
pathogen, administered subcutaneously and leading to arthritis
[37], Staphylococcus aureus is a Gram positive pathogen, adminis-
tered intravenously leading to severe sepsis with pronounced
pulmonary lesions [38], Actinobacillus pleuropneumoniae is a Gram
negative agent, administered intranasally [30[or through inhala-
tion of an aerosol [34] and infecting the lung, and, finally,
inflammation was created by localized subcutaneous aseptic
injection of turpentine [35]. Thus, the negative acute phase
response of pig AGP is not confined to a single type of infection or
inflammation. Instead, it is indicated to be a general pig AGP
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acute phase response type resembling e.g. the response of
apolipoprotein A-1 which is also a negative acute phase protein
in the pig (and many other species) [55]. As AGP is generally
described as a positive acute phase protein in all species, pig AGP
has been used in a number of cases for monitoring acute phase
responses (e.g. [23], [24], [25], [26]). However, Lampreave et al
[27] and Eckersall et al. [28] both described AGP as not changing
its serum concentration during the acute phase protein response to
inflammation, and this was also reported by Asai et al. [29] after
experimental porcine reproductive and respiratory syndrome virus
infection. Kahlisch et al. [12] described pig AGP in BALF as a
negatively reacting acute phase protein after experimental
Actinobacillus pleuropneumoniae serotype 7 infection. However, this
analysis was done on the subset of bronchoalveolar fluid
glycoproteins binding to the lectin concanavalin A, and the
negative response was only seen for the Pie´train breed as opposed
to German Landrace (for which an increase was seen) and
Hampshire breed (for which there was no change). The decrease
in the Pie´train breed was concluded by the authors to probably not
reflect the acute phase response of unfractionated serum AGP and
was not further discussed. The source of BALF pig AGP was not
investigated (infiltrating neutrophils as opposed to lung tissue
derived) and quantification was done by densitometry of silver-
stained 2-D gels. Finally, Yang et al. [31] reported the identifi-
cation of a single down-regulated spot in two-dimensional
electrophoresis of serum from pigs challenged with a highly
pathogenic porcine respiratory and reproductive syndrome virus
type as pig AGP, however these authors were not able to confirm
down-regulation of overall pig AGP by one-dimensional Western
blotting using an antibody raised against recombinantly expressed
pig AGP [31].
We previously reported a moderate but significant down-
regulation of the pig AGP gene (ORM1) in liver tissue at 24 hours
after experimental infection with Actinobacillus pleuropneumoniae
serotype 5b [21], and this is now confirmed to be reflected in
the circulating concentrations of pig AGP protein. Furthermore
we demonstrate here that hepatic expression of ORM1 was also
decreased at 24 hours after experimental Actinobacillus pleuropneu-
moniae serotype 2 and 6 infection, dropping to 25% (serotype 6)
and 50% (serotype 2) simultaneously with an increase in
expression of the positive acute phase protein pig MAP of 10–20
times. Finally, the same degree of hepatic down-regulation of the
pig ORM1 gene was shown after experimental Staphylococcus aureus
infection, accompanied by a more than 10 fold increase in pig
MAP expression.
Although these results clearly show that pig AGP is down-
regulated as a part of the general acute phase response, other
factors may be at play controlling this response. For example it was
observed that experimental infection (aerosol) with pig influenza
type A subtype H1N2 (Large White/German Landrace cross-
breds, described in [47]) led to a small, positive pig AGP serum
response (unpublished). Also, two other experimental infection
studies (Lawsonia intracellularis (oral) in Danish Landrace/York-
shire/Duroc crossbreds and Toxoplasma gondii (oral) in Danish
Landrace/Yorkshire crosses) resulted in a well-differentiated acute
phase protein response [56], [57], however caused no change in
pig AGP serum concentrations as determined with the ELISA
developed here (unpublished). It is also worth noting that obese
Ossabaw minipigs (in contrast to obese Go¨ttingen minipigs and
obese domestic Landrace/Yorkshire crosses) showed an increase
in pig AGP serum concentrations in obesity [58] resembling
observations in mice and humans. It is not known how pig AGP
reacts during the acute phase response in Ossabaw pigs.
The bronchoalveolar fluid glycoprotein results of [12] may
indicate that there are differences between pig breeds in the acute
phase response of pig AGP, and some, but not all, of the above
observations may be explained by breed-dependent responses,
however we have no systematic data to back this up. It is not
unseen that different breeds of the same species may show different
acute phase response patterns with specific acute phase proteins;
this was for example observed for serum amyloid P protein in
different mouse strains [59]. Also, the fact that pig AGP is
dramatically regulated during development as shown by us and
others [5], [8], [9] indicates that pig AGP synthesis is controlled by
several different mechanisms. Finally, as reported in this paper,
there seem to be big differences between non-induced serum pig
AGP concentrations within and between a number of different pig
breeds, as well as (especially) between differently reared pigs. It was
especially intriguing that Yorkshire as well as Landrace pigs in
normal herds had a much higher median pig AGP serum
concentration than Landrace/Yorkshire crosses kept at experi-
mental facilities. These data clearly warrant further, systematic
studies on pig AGP during the acute phase response to specific
infections comparing different pig breeds and different herds/
breeders.
To summarize, we purified and extensively characterized
purified pig AGP from pooled Landrace pig serum showing that,
as in other species, it is an extensively glycosylated, very acidic
microheterogeneous glycoprotein. Furthermore an immunoassay
was established for the quantification of pig AGP and it was shown
that this protein shows a hitherto undescribed acute phase
response pattern during a range of different infections as well as
after induced inflammation. This is the first description of AGP in
any species as a true negative acute phase protein. Pig AGP serum
concentrations, however, also seemed to be influenced by other
factors, including possibly breed type, age and housing as well as
handling. Its different types of responses, including the response to
obesity in the Ossabaw breed [58] should be investigated further
to establish if pig AGP might be useful as an acute phase
biomarker with increased differential diagnostic abilities as
compared to classically behaving acute phase proteins. Finally,
the differences in the acute phase response of AGP (and other
acute phase proteins) between species adds to the speculations on
its biological function as well as on the biological function of the
acute phase protein response itself.
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